BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 30723502)

  • 1. Autophagy Regulated by Gain of Function Mutant p53 Enhances Proteasomal Inhibitor-Mediated Cell Death through Induction of ROS and ERK in Lung Cancer Cells.
    Saini H; Hakeem I; Mukherjee S; Chowdhury S; Chowdhury R
    J Oncol; 2019; 2019():6164807. PubMed ID: 30723502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chloroquine induces transitory attenuation of proliferation of human lung cancer cells through regulation of mutant P53 and YAP.
    Saini H; Choudhary M; Sharma H; Chowdhury S; Mukherjee S; Chowdhury R
    Mol Biol Rep; 2023 Feb; 50(2):1045-1058. PubMed ID: 36385665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of glucosylceramide synthase eliminates the oncogenic function of p53 R273H mutant in the epithelial-mesenchymal transition and induced pluripotency of colon cancer cells.
    Hosain SB; Khiste SK; Uddin MB; Vorubindi V; Ingram C; Zhang S; Hill RA; Gu X; Liu YY
    Oncotarget; 2016 Sep; 7(37):60575-60592. PubMed ID: 27517620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteasomal and autophagy-mediated degradation of mutp53 proteins through mitochondria-targeting aggregation-induced-emission materials.
    Wang M; Yang Z; Song Y; Wei P; Ishiwme N; Wang L; Zhang H; Jing M; Gao M; Wen L; Zhang Y
    Acta Biomater; 2022 Sep; 150():402-412. PubMed ID: 35931280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gain-of-function mutant p53 upregulates CXC chemokines and enhances cell migration.
    Yeudall WA; Vaughan CA; Miyazaki H; Ramamoorthy M; Choi MY; Chapman CG; Wang H; Black E; Bulysheva AA; Deb SP; Windle B; Deb S
    Carcinogenesis; 2012 Feb; 33(2):442-51. PubMed ID: 22114072
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CQ synergistically sensitizes human colorectal cancer cells to SN-38/CPT-11 through lysosomal and mitochondrial apoptotic pathway via p53-ROS cross-talk.
    Chen P; Luo X; Nie P; Wu B; Xu W; Shi X; Chang H; Li B; Yu X; Zou Z
    Free Radic Biol Med; 2017 Mar; 104():280-297. PubMed ID: 28131902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Androgen-independent growth of LNCaP prostate cancer cells is mediated by gain-of-function mutant p53.
    Nesslinger NJ; Shi XB; deVere White RW
    Cancer Res; 2003 May; 63(9):2228-33. PubMed ID: 12727844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hsp90 Inhibitor SNX-2112 Enhances TRAIL-Induced Apoptosis of Human Cervical Cancer Cells via the ROS-Mediated JNK-p53-Autophagy-DR5 Pathway.
    Hu L; Wang Y; Chen Z; Fu L; Wang S; Zhang X; Zhang P; Lu X; Jie H; Li M; Wang Y; Liu Z
    Oxid Med Cell Longev; 2019; 2019():9675450. PubMed ID: 31019655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Triptolide promotes degradation of the unfolded gain-of-function Tp53
    Zhou J; Luo J; Li P; Zhou Y; Li P; Wang F; Mallio CA; Rossi G; Jalal AH; Filipovic N; Tian Z; Zhao X
    Transl Lung Cancer Res; 2022 May; 11(5):802-816. PubMed ID: 35693277
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gain-of-function p53 activates multiple signaling pathways to induce oncogenicity in lung cancer cells.
    Vaughan CA; Singh S; Grossman SR; Windle B; Deb SP; Deb S
    Mol Oncol; 2017 Jun; 11(6):696-711. PubMed ID: 28423230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NF-κB is involved in the regulation of autophagy in mutant p53 cells in response to ionizing radiation.
    Zhu Y; Zuo W; Shen X; Liu Y; Zhao Y; Xiong Y; Cao H; Wang Y; Liang Z
    Cell Death Discov; 2021 Jun; 7(1):159. PubMed ID: 34226514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Harnessing the vulnerabilities of p53 mutants in lung cancer - Focusing on the proteasome: a new trick for an old foe?
    Oduah EI; Grossman SR
    Cancer Biol Ther; 2020 Apr; 21(4):293-302. PubMed ID: 32041464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction between p53 and Ras signaling controls cisplatin resistance via HDAC4- and HIF-1α-mediated regulation of apoptosis and autophagy.
    Zhang X; Qi Z; Yin H; Yang G
    Theranostics; 2019; 9(4):1096-1114. PubMed ID: 30867818
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p53-R273H Sustains ROS, Pro-Inflammatory Cytokine Release and mTOR Activation While Reducing Autophagy, Mitophagy and UCP2 Expression, Effects Prevented by wtp53.
    Romeo MA; Gilardini Montani MS; Benedetti R; Arena A; D'Orazi G; Cirone M
    Biomolecules; 2021 Feb; 11(3):. PubMed ID: 33668399
    [No Abstract]   [Full Text] [Related]  

  • 15. Transcriptome profiling identifies genes and pathways deregulated upon floxuridine treatment in colorectal cancer cells harboring GOF mutant p53.
    Datta A; Dey S; Das P; Alam SK; Roychoudhury S
    Genom Data; 2016 Jun; 8():47-51. PubMed ID: 27114909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gain-of-function mutant p53 promotes the oncogenic potential of head and neck squamous cell carcinoma cells by targeting the transcription factors FOXO3a and FOXM1.
    Tanaka N; Zhao M; Tang L; Patel AA; Xi Q; Van HT; Takahashi H; Osman AA; Zhang J; Wang J; Myers JN; Zhou G
    Oncogene; 2018 Mar; 37(10):1279-1292. PubMed ID: 29269868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of ERK-p53 and ERK-mediated phosphorylation of Bcl-2 are involved in autophagic cell death induced by the c-Met inhibitor SU11274 in human lung cancer A549 cells.
    Liu Y; Yang Y; Ye YC; Shi QF; Chai K; Tashiro S; Onodera S; Ikejima T
    J Pharmacol Sci; 2012; 118(4):423-32. PubMed ID: 22466960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunomodulatory proteins FIP-gts and chloroquine induce caspase-independent cell death via autophagy for resensitizing cisplatin-resistant urothelial cancer cells.
    Hsin IL; Wang SC; Li JR; Ciou TC; Wu CH; Wu HM; Ko JL
    Phytomedicine; 2016 Dec; 23(13):1566-1573. PubMed ID: 27823620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mimulone-induced autophagy through p53-mediated AMPK/mTOR pathway increases caspase-mediated apoptotic cell death in A549 human lung cancer cells.
    An HK; Kim KS; Lee JW; Park MH; Moon HI; Park SJ; Baik JS; Kim CH; Lee YC
    PLoS One; 2014; 9(12):e114607. PubMed ID: 25490748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination of Proteasome and Histone Deacetylase Inhibitors Overcomes the Impact of Gain-of-Function p53 Mutations.
    Meng X; Yang S; Li Y; Li Y; Devor EJ; Bi J; Wang X; Umesalma S; Quelle DE; Thiel WH; Thiel KW; Leslie KK
    Dis Markers; 2018; 2018():3810108. PubMed ID: 30647797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.